AS Medication Didn't Change Heart Risks
A long term disease named Ankylosing Spondylitis has been linked to a higher risk of cardiovascular problems. A number of factors could be responsible for this increased risk, including the drugs used to treat this painful condition.
To Switch or Not To Switch AS Drugs
No two patients with ankylosing spondylitis are exactly the same. As such, a drug treatment that works for one patient may not work for the other. When one drug isn't working out, patients may turn to another drug.
RA Drugs Carry Similar Risk
Many experts recommend that rheumatoid arthritis patients get early drug treatment to slow down their disease and prevent disability. With so many drug options, it's important to know the safety of each drug.
No Doubt About Arthritis Drug's Benefit
A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Psoriasis Drugs Not Linked to Cardiovascular Problems
Early reports indicating drugs treating psoriasis were linked to major cardiovascular events seem to lack evidence.